Targeting the tumor and its microenvironment by a dual-function decoy Met receptor - PubMed (original) (raw)
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
Paolo Michieli et al. Cancer Cell. 2004 Jul.
Free article
Abstract
Met, the receptor for hepatocyte growth factor (HGF), is activated in human cancer by both ligand-dependent and -independent mechanisms. We engineered a soluble Met receptor (decoy Met) that interferes with both HGF binding to Met and Met homodimerization. By lentiviral vector technology, we achieved local or systemic delivery of decoy Met in mice. We provide evidence that in vivo expression of decoy Met (1) inhibits tumor cell proliferation and survival in a variety of human xenografts, (2) impairs tumor angiogenesis by preventing host vessel arborization, (3) suppresses or prevents the formation of spontaneous metastases, and (4) synergizes with radiotherapy in inducing tumor regression, without (5) affecting housekeeping physiological functions in the adult animal.
Comment in
- Met decoys: will cancer take the bait?
Zhang YW, Graveel C, Shinomiya N, Vande Woude GF. Zhang YW, et al. Cancer Cell. 2004 Jul;6(1):5-6. doi: 10.1016/j.ccr.2004.07.003. Cancer Cell. 2004. PMID: 15261136
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous